# F5 — Care Coordination Platforms (family + professional; severe-disease)

**Market Deep Dive brief · 1 of 8 · drafted 2026-06-09**

Source grades inline: **[P]** primary (regulator, peer-reviewed, company SEC/funding filing), **[S]** reputable secondary (trade press, analyst), **[V]** vendor self-report. Figures I could not independently confirm are flagged «unverified». All non-obvious claims carry a URL in the citations list.

This brief deliberately does NOT re-cover the basic family-coordination mechanics (CaringBridge, Lotsa, Jointly, Caren-as-message-board, Hello 24/7) — Ditto already has that analysis. It extends into the two monetization-rich gaps that prior analysis missed, and answers one strategic question: **is coordination a real standalone market for Ditto, or always a feature?**

---

## (a) Field map — where the money actually is

Coordination is a crowded feature graveyard at the consumer layer. The two places where someone *pays real money* sit at the edges, and both are structurally American.

| Layer | Who pays | Mechanic | Money? | Already covered by Ditto? |
|---|---|---|---|---|
| **Consumer family coordination** | Nobody, or the family (low willingness) | Shared calendar, updates, meal trains | Weak. Donation/freemium. Graveyard. | Yes — prior analysis. **Skip here.** |
| **Employer-paid caregiving concierge** | **Employer** (HR benefit) | Care coach + logistics for the working caregiver | **Strong. PEPM / PMPM.** Wellthy ~$56M rev [S]. | **No — GAP 1, this brief.** |
| **Value-based oncology navigation** | **Payer / risk-bearing provider** | Nurse-led navigation tied to total-cost-of-care shared savings | **Strong. PMPM + shared savings.** Thyme Care $178M raised [S]. | **No — GAP 2, this brief.** |
| **NL/EU professional coordination** | Care org (EHR seat) or municipality | EHR-tethered family/professional portal | Modest, B2B SaaS to care orgs. | Partly — positioned below. |

**The pattern that matters for Ditto:** in every case where coordination makes money, the payer is an *institution buying an outcome* (lower attrition, lower total cost of care), never a family buying a nicer message thread. Coordination monetizes only when it is bolted to a cost the institution already carries. That is the central finding, and it shapes the lean-in/skip read.

---

## (b) Player teardowns

### GAP 1 — Employer-paid caregiving (the missing monetization unlock)

**The model in one line:** the US gives employers a tax-advantaged reason to buy health-adjacent benefits, and ~1 in 5 employees is a working caregiver whose divided attention costs the employer in turnover and absenteeism. A concierge that reduces that loss pays for itself. The buyer is HR; the user is the caregiver; the product is a human care coach plus logistics.

#### Wellthy — the category leader

| Lens | Read |
|---|---|
| **1. Job & moment** | "My parent/spouse/child got seriously ill and I'm drowning in logistics while trying to keep my job." Concierge takes the admin load: finding providers, appeals, in-home care, paperwork. |
| **2. Sticky mechanic** | A named human **Care Coordinator** owns the family's "Care Project." Trust + offloaded work = stickiness. Software is the wrapper, the human is the moat. |
| **3. Frequency engine** | Episodic-but-intense: heavy during a crisis, dormant between. Retention is employer-contract-driven, not daily-engagement-driven. |
| **4. Monetization** | **Employer pays, PEPM/eligible-population model** «exact PEPM unverified — not public». Scale: ~$56.2M revenue, ~$168.6M valuation, ~$75–80M raised, 251–500 staff [S, getlatka/CBInsights]. Clients incl. Best Buy, Merck, Harvard [S]. **Evidence the buyer is real:** HBS (Joseph Fuller, Project on Managing the Future of Work) independently analyzed ~100 Wellthy clients — turnover down 1–7%, absenteeism down 10–50%, ~126% ROI / 2:1–3.6:1 [S, HBS + Wellthy]. This is the single best "the employer will pay" evidence base in the category. |
| **5. Defensibility / moat** | Human care-coach network + employer distribution + accumulated case-resolution playbooks. Hard to copy fast; not a software moat. |
| **6. Outcome & graveyard lesson** | Healthy, growing, bootstrapped-feel revenue. Lesson: **the human concierge — not the app — is what HR buys.** A pure-software coordination tool would not clear this bar. |
| **7. EU-applicability** | **Low, structurally.** The HBS ROI math is real, but the *buying motion* depends on the US benefits market (see structural note below). NL equivalent is the `mantelzorgmakelaar`, not a SaaS seat. |

#### Cariloop — same model, coaching-forward

| Lens | Read |
|---|---|
| **1–3. Job / sticky / frequency** | Same caregiver job. Sticky mechanic = named **Care Coach** + backup care. Episodic frequency, contract retention. |
| **4. Monetization** | **Employer per-employee subscription + usage-based coaching**, sold through benefits brokers/marketplaces (Benefitfocus) [S]. $20M Series C, Apr 2024 [P/S, Axios/Yahoo]. Revenue grew ~300% 2021–2024, Inc. 5000 [S]. **NRR ~120%, NPS >80, ~2.5x ROI claim** [V, Cariloop]. Clients: P&G, KPMG, Insperity, American Cancer Society [V]. |
| **5. Moat** | Broker/marketplace distribution + coach network. Same human-led moat as Wellthy. |
| **6. Graveyard lesson** | None yet — growing. Reinforces that **distribution through benefits brokers is the real channel**, which does not exist in NL/EU in the same form. |
| **7. EU-applicability** | **Low**, same reason as Wellthy. |

#### ianacare — lighter-touch, multi-payer, watch the pivot

| Lens | Read |
|---|---|
| **1. Job & moment** | "Rally my circle to help" — a free **Caregiver Organizer** (tasks/help requests to friends and family) as the front door. |
| **2–3. Sticky / frequency** | Free organizer for acquisition; **ianacare PLUS** (human Caregiver Navigators) for monetized support. Circle-rallying is the viral/frequency hook. |
| **4. Monetization** | **Multi-payer and migrating.** Originally employer-paid (Series A $12.1M, ~$16.7M total, Greycroft, Jan 2022) [P/S, TechCrunch/BusinessWire]. **Now pushing into payers and the CMS GUIDE dementia model** (provider/Medicare-funded caregiver support infrastructure) and partners with Elevance Health, AARP [S, MIT News / ianacare]. ~50,000 caregivers served [S/V]. |
| **5. Moat** | The free organizer + circle network effect; thinner human layer than Wellthy/Cariloop. |
| **6. Outcome & graveyard lesson** | **The most strategically instructive of the three.** ianacare is drifting *off* pure employer-pay toward **government/payer reimbursement (GUIDE)** because the regulator created a billable line item for caregiver support. Lesson for Ditto: **the durable money follows whoever creates a reimbursement code, not the consumer.** |
| **7. EU-applicability** | The free-organizer + circle layer is the most Ditto-like and most portable. The *paid* layer still depends on US payer/employer plumbing. |

**Structural note — is employer-paid caregiving transferable to NL/EU?**

| Factor | US | NL/EU |
|---|---|---|
| Why employers buy health-adjacent benefits | Healthcare is employer-sponsored and tax-excluded; the benefit "glue" is decades old. >60% of non-elderly insured via employer [S, KFF/Cato]. | Universal coverage (Zvw/Wlz). Employers do **not** carry the health-spend, so the "buy a benefit to manage our cost" reflex is far weaker. |
| Caregiver prevalence | ~1 in 5 workers | **~1 in 4 workers (~2M), 1 in 3 in the care sector** [S, Aon NL] — the *problem* is at least as big. |
| Existing employer mechanism | Concierge SaaS seat sold via brokers | **`mantelzorgmakelaar`** (a paid human broker, often reimbursed via supplementary insurance), statutory care leave (`zorgverlof`), and a *non-monetary* **"Wij werken mantelzorgvriendelijk"** certification [S, Business.gov.nl / aandeslagmetmantelzorg]. |
| Net | A SaaS-seat benefits market exists and is large. | The *need* exists; the *paid SaaS-seat buying motion* mostly does not. Support is delivered as leave policy + human broker, not a per-employee software license. |

**Verdict on GAP 1: the employer-paid caregiving model is substantially a US-benefits-market artifact.** The underlying caregiver pain is equal or larger in NL, and the ROI logic is sound, but the *channel* (benefits brokers selling PEPM seats to employers who carry health cost) does not transfer. An NL equivalent would more likely be sold to **health insurers (Zvw supplementary), large employers as a thin pilot, or via the `mantelzorgmakelaar` reimbursement rail** — not as a US-style HR-benefit SaaS line. Transferable as a *problem*, not as a *go-to-market*.

---

### GAP 2 — Value-based oncology navigation

**The model in one line:** in the US, a risk-bearing payer (Medicare Advantage, EOM-participating practice, commercial at-risk) is on the hook for the *total cost* of a cancer patient. Avoidable ER visits and admissions are the leak. A nurse-led navigation layer that catches symptoms early and steers care plugs the leak, and gets paid a PMPM fee plus a slice of the savings. **The payer's downside risk is the entire business model.**

#### Thyme Care — the standout

| Lens | Read |
|---|---|
| **1. Job & moment** | From diagnosis onward: 24/7 virtual navigation (oncology nurses, social workers, navigators) between appointments, when most avoidable cost is generated. |
| **2. Sticky mechanic** | Embedded in the patient's actual treatment + integrated with 800+ oncologists (Thyme Care Oncology Partners) [S]. Clinical integration, not a side app. |
| **3. Frequency engine** | Continuous proactive outreach + ePRO symptom monitoring + ADT/claims feeds triggering intervention. Engagement is operationally manufactured, not user-pull. |
| **4. Monetization** | **Payer- and risk-paid: PMPM + shared savings / value-based contracts** across Medicare Advantage and commercial. EmblemHealth (3M members) is a flagship payer deal [S]. Scale: **$95M Series C Jul 2024 ($55M equity + $40M debt), ~$178M total raised, $480M valuation** [P/S, PRNewswire/Crunchbase]; CVS Health Ventures, Town Hall, a16z Bio+Health [S]. Projecting 4x growth / 40,000+ patients in 2025 [V]. |
| **5. Defensibility / moat** | Payer contracts + oncologist network + the data/operations to actually *hit* savings benchmarks. The moat is being trusted with financial risk. |
| **6. Outcome & evidence** | **Best real-outcome evidence in this brief, with caveats.** Partner American Oncology Network reported **~$6M Medicare savings in EOM's first performance period (started Jul 1 2023)**, crediting pharmacy interventions (drug-waste minimization, therapeutic substitution), navigation, and virtual palliative care [S, AJMC / Thyme Care / AON]. Caveats: it is a *partner practice's* result reported jointly with the vendor; whether it nets MEOS fees and how it generalizes is «unverified»; single performance period. Directionally real, not yet a slam dunk. |
| **7. EU-applicability** | **Low without a risk-bearing payer.** No NL entity holds total-cost-of-care oncology risk the way a US MA plan or EOM practice does (see EU analog below). |

#### Jasper Health — cautionary tale

| Lens | Read |
|---|---|
| **1–3. Job / mechanic** | AI + human cancer navigation, planning tools, personalized guidance. |
| **4. Monetization** | Pivoted toward **Medicare-focused navigation aligned to new CMS reimbursement codes (PIN/navigation)** [S]. ~$37.8M raised (incl. $25M Series A, General Catalyst) [S, Fierce/Crunchbase]. |
| **6. Outcome & graveyard lesson** | **Laid off ~half of ~48 staff in May 2024** [S, TechCrunch/Becker's]; still operating, restructured around CMS codes. **Lesson: navigation without being the entity that holds (or directly bills) the risk is fragile.** Thyme Care holds contracts; Jasper chased codes and had to cut. |
| **7. EU-applicability** | Low — same payer-dependence, and the cautionary signal applies doubly in the EU where the reimbursement codes don't exist. |

#### Memora Health — exited into infra, the most telling outcome

| Lens | Read |
|---|---|
| **1–3. Job / mechanic** | "Intelligent care enablement" — AI-driven automation of high-touch clinical workflows, two-way patient messaging, routing patient-reported data to care teams. Sold to health systems, plans, digital-health cos. |
| **4. Monetization** | B2B2C / B2B SaaS to institutions (not consumers). |
| **6. Outcome & graveyard lesson** | **Acquired by Commure (all-stock, undisclosed) Dec 2024** [P/S, GlobeNewswire/Axios], folded into a broader AI healthcare-infra platform. **Lesson: standalone "navigation/coordination" did not sustain as an independent company — it became a feature of a clinical-ops platform.** This is the single strongest data point that coordination tends to resolve into a feature, not a company. |
| **7. EU-applicability** | As infra it is portable in theory; as a business it validates "coordination → feature." |

**EU analog to value-based oncology navigation — is there one?**

| US ingredient | NL/EU equivalent | Gap |
|---|---|---|
| Risk-bearing payer who profits from avoided cost | **Largely absent.** Zvw insurers contract hospitals but rarely hold a navigation-enabler at total-cost-of-care risk. | No buyer with the same financial incentive. |
| Per-patient navigation fee (EOM MEOS $70→$110 PMPM from 2025) [P, CMS] | No standing oncology-navigation PMPM line. | No billable code for an external navigator. |
| Outcome accountability | **Santeon `uitkomstgerichte zorg`** — 7-hospital VBHC network, real results (e.g. ~30% fewer unnecessary breast-cancer inpatient stays, lumpectomy reoperation down ~15% avg / ~60% best hospital) [P, ICHOM/NEJM Catalyst/BCG]. | This is **provider-led outcome improvement, not a third-party navigation enabler getting paid on shared savings.** The model improves care; it does not create a vendor revenue line. |
| Nurse navigators | Exist clinically (often hospital-employed specialist nurses), but **no standing external-reimbursement rail** comparable to CMS PIN/EOM. | The role exists; the *payment for an outside platform to do it* does not. |

**Verdict on GAP 2: value-based oncology navigation does NOT work in NL/EU today, because the thing that pays for it — a risk-bearing payer who keeps the savings — is missing.** The closest EU cousin, Santeon, is hospitals improving their own outcomes, which generates clinical value but no enabler revenue line. Any EU version would have to be sold as a *cost/quality tool to hospitals or insurers under existing DBC/contract budgets*, on a much smaller and slower commercial basis, and without the shared-savings upside that funds Thyme Care's $178M.

---

### NL / professional coordination layer (brief positioning)

| Player | Model | Who pays | What it implies for Ditto |
|---|---|---|---|
| **Caren (Nedap Ons)** | Family/client portal **tethered to the Ons EHR**; auto-available to orgs on Ons; MedMij-compliant [V/S]. | The **care organization** (via its EHR), not the family. | The dominant NL pattern is **EHR-tethered**. Coordination is bundled into the system of record. A standalone family coordination layer competes with something already free-to-the-family inside the EHR. |
| **OZOverbindzorg** | Independent non-profit network platform; patient controls who joins; connects mantelzorg + professionals + municipality [S]. | **Municipalities and health insurers** fund it; free to client/caregiver. | Shows the NL funding reality: coordination gets paid by **public/insurer budgets**, not consumers — and even then as a thin non-profit, not a venture-scale business. |
| **Familienet** | Family-communication app for care homes since 2005; 1000+ orgs across NL/BE/DE/NO/UK [V]. | **Care organization**, **€99/month per location** [V]. | Coordination as a low-ticket B2B SaaS sold to facilities. Viable but small; it is a facility add-on, not a patient-owned platform. |

**Implication:** the NL professional layer is EHR-tethered or institution-funded, low-ticket, and already occupies the "neutral family portal" position. Ditto entering here head-on means competing with Nedap's distribution and free-to-family economics. Ditto's wedge is the *opposite* end — patient-owned, conversation-derived understanding — not the institutional record.

---

## (c) White space for Ditto — plain read

**Three questions, three answers:**

1. **Is employer-paid caregiving transferable to NL/EU?** Mostly **no, as a go-to-market**. The pain is equal or bigger (1 in 4 NL workers), but the US buying motion (brokers selling PEPM seats to employers who carry health cost) does not exist. NL delivers this as statutory leave + `mantelzorgmakelaar` + a non-paid "caregiver-friendly" badge. A paid version would route through **insurers (Zvw supplementary) or the mantelzorgmakelaar rail**, not HR SaaS seats. Treat as a *long-shot insurer/employer pilot*, not a beachhead.

2. **Does value-based oncology navigation work without a US-style risk-bearing payer?** **No.** The entire model is funded by a payer keeping avoided cost. NL has no equivalent payer at oncology total-cost risk and no navigation PMPM code. The EU analog (Santeon) is provider-led outcome work that produces clinical value but **no enabler revenue line**. This is not a near-term EU market.

3. **Net — is care coordination a real standalone market "if done extremely well," or structurally a feature?** **Structurally a feature, with one narrow conditional exception.** The graveyard is unambiguous: Memora got absorbed into infra, Jasper cut half its staff, consumer coordination doesn't monetize, and the NL layer is EHR-bundled and institution-funded. **Coordination only became a *company* when it was bolted to an institutional cost (employer attrition, payer total-cost-of-care) the institution already owned.** Ditto owns no such cost and sells to neither US employers nor US payers. So for Ditto, coordination is a **lean-in feature, not a spine** — which is exactly the "own-perspective-v2" reframe, now evidence-backed.

**The recommendation: EXPERIMENT LIGHTLY, do not lean in as a market, do not skip the feature.**

| Path | Read |
|---|---|
| **Lean in (build coordination as a market)** | **No.** No EU payer/employer buying motion; you'd be fighting Nedap on its turf with worse distribution. |
| **Experiment lightly (coordination as a Ditto feature)** | **Yes.** Ditto's unique input — the *understood* medical conversation — is the one coordination asset competitors lack. The care circle around a severe-disease patient is the right place to seed sharing. Ship the lightest possible "share this summary + next steps with my circle" loop. Measure circle invites and re-engagement. This is a growth/retention play, not a revenue line. |
| **Skip** | **No** — skipping the feature forfeits Ditto's natural virality wedge in the oncology beachhead. |

**One honest opposing view:** if NL/EU moves toward **principal-illness-navigation-style reimbursement** (the direction ianacare is chasing via CMS GUIDE, and that Dutch insurers occasionally pilot), the calculus changes. The thing to watch is not a competitor product — it is whether a Dutch insurer or the regulator ever creates a *billable line* for navigating a severe-disease patient. If that appears, coordination could become a market in NL. Until then, treat the standalone-market thesis as unfunded.

**Needs Merlijn's input / could not verify:**
- Exact PEPM/PMPM prices for Wellthy, Cariloop, ianacare are **not public** — flagged «unverified» throughout. If pricing precision matters for a model, this needs a sales-call or broker source.
- The AON/Thyme $6M EOM saving is a *partner-reported, single-period, vendor-co-announced* figure; net-of-fees and durability are «unverified».
- Whether any Dutch insurer is currently piloting a paid severe-disease navigation line is the key unknown that would move the verdict — worth a direct check (Zilveren Kruis / VGZ innovation desks).

---

## (d) Citations (graded)

**Employer-paid caregiving**
- Wellthy, HBS ROI research summary [S/V] — https://wellthy.com/blog/harvard-business-school-roi-benefits-caregiving
- HBS Institute for Business in Global Society, caregiving ROI [S] — https://www.hbs.edu/bigs/caregiving-can-show-measurable-gains
- Harvard Kennedy School "Healthy Outcomes" caregiving study [S] — https://pw.hks.harvard.edu/post/healthy-outcomes-how-employers-support-for-employees-with-caregiving-responsibilities-can-benefit
- Wellthy revenue/valuation ($56.2M / $168.6M) [S] — https://getlatka.com/companies/Wellthy
- Wellthy funding/financials [S] — https://www.cbinsights.com/company/wellthy/financials
- Cariloop $20M Series C, Apr 2024 [S] — https://www.axios.com/pro/health-tech-deals/2024/04/09/cariloop-corrals-20m-to-expand-caregiver-solutions
- Cariloop Series C / growth [S] — https://finance.yahoo.com/news/cariloop-secures-20-million-series-120000793.html
- Cariloop on Benefitfocus marketplace [S] — https://www.benefitfocus.com/solutions/catalog/cariloop/caregiver-support-platform
- Cariloop ROI/NRR/NPS claims [V] — https://cariloop.com/blog/empowering-employee-well-being-the-roi-of-caregiver-support-solutions
- ianacare $12.1M Series A [P/S] — https://www.businesswire.com/news/home/20220104005098/en/ianacare-Raises-%2412.1M-to-Fundamentally-Change-the-Family-Caregiver-Experience ; https://techcrunch.com/2022/01/04/ianacare-picks-up-12-1m-to-fundamentally-change-the-family-caregiver-experience/
- ianacare → CMS GUIDE / payer pivot, Elevance/AARP, 50k caregivers [S] — https://news.mit.edu/2025/ianacare-builds-lifeline-for-family-caregivers-across-us-0811 ; https://ianacare.com/resource-center/nfcm-2024-review/

**US benefits-market structure (the "why")**
- KFF, employer-sponsored insurance 101 [S] — https://www.kff.org/health-costs/health-policy-101-employer-sponsored-health-insurance/
- Cato, tax exclusion as the "glue" [S] — https://www.cato.org/policy-analysis/end-tax-exclusion-employer-sponsored-health-insurance-return-1-trillion-workers-who

**NL employer-caregiver reality**
- Business.gov.nl, employee carer leave (`zorgverlof`) [P/S] — https://business.gov.nl/staff/health-and-safety/your-employee-is-a-caregiver-types-of-leave/
- Aon NL, impact of informal care on employers (1 in 4 / 1 in 3) [S] — https://www.aon.com/nl-nl/insights/articles/locations/nl/the-impact-of-informal-care-on-employers
- "Wij werken mantelzorgvriendelijk" certification + business case [S] — https://www.aandeslagmetmantelzorg.nl/over-mantelzorg/wat-levert-mantelzorgvriendelijk-werken-op
- Mantelzorgmakelaar / employer support framing [S] — https://www.unie.nl/en/jouw-werk-en-inkomen/financial-support-for-working-caregivers

**Value-based oncology navigation**
- Thyme Care $95M Series C, $178M total, $480M val [P/S] — https://www.prnewswire.com/news-releases/thyme-care-closes-95m-series-c-to-fuel-cancer-care-affordability-302197293.html ; https://www.crunchbase.com/funding_round/thyme-care-series-c--42fff628
- Thyme Care 4x growth / 40k patients / EmblemHealth [V/S] — https://www.prnewswire.com/news-releases/thyme-care-projects-4x-growth-in-2025-302334280.html
- AON + Thyme Care ~$6M EOM savings, drivers [S] — https://www.ajmc.com/view/with-thyme-care-partnership-aon-achieves-6m-in-savings-in-eom-s-first-performance-period ; https://www.aoncology.com/2025/04/22/american-oncology-network-achieves-success-in-first-performance-period-of-cmmis-enhancing-oncology-model/
- CMS EOM / MEOS $70→$110 PMPM, model design [P] — https://www.cms.gov/priorities/innovation/innovation-models/enhancing-oncology-model/second-cohort-fact-sheet ; https://www.ajmc.com/view/cms-reopens-eom-with-payment-boost-extends-model-to-2030
- Jasper Health layoffs May 2024, ~$37.8M raised [S] — https://techcrunch.com/2024/05/31/general-catalyst-backed-jasper-health-lays-off-staff/ ; https://www.fiercehealthcare.com/digital-health/former-cvs-health-exec-gets-25m-cancer-care-navigation-platform-jasper-health
- Memora Health acquired by Commure, Dec 2024 [P/S] — https://www.globenewswire.com/news-release/2024/12/20/3000557/0/en/Commure-Acquires-Memora-Health-a-Digital-Care-Navigation-Platform-to-Enhance-Intelligent-Care-Navigation.html ; https://www.axios.com/pro/health-tech-deals/2024/12/20/medical-ai-commure-acquires-memora-health-care-automation-general-catalyst
- CMS Principal Illness Navigation (PIN) codes, Jan 2024 [P/S] — https://www.ons.org/publications-research/voice/advocacy/04-2024/what-new-cms-reimbursement-principal-illness

**EU value-based oncology analog**
- Santeon VBHC results [P/S] — https://catalyst.nejm.org/doi/10.1056/CAT.23.0232 ; https://ichom.org/files/case-studies/Santeon_Case_Study_Final.pdf ; https://www.bcg.com/publications/2018/how-dutch-hospitals-make-value-based-health-care-work

**NL professional coordination layer**
- Caren (Nedap Ons), EHR-tethered, MedMij [V/S] — https://www.carenzorgt.nl/ ; https://nedap-ons.nl/ons-suite/meer/caren/
- OZOverbindzorg, municipality/insurer-funded non-profit [S] — https://www.knmp.nl/dossiers/kwetsbare-ouderen/best-practices-ouderenzorg/best-practice-ozoverbindzorg ; https://zorginnovatie.nl/innovaties/ozoverbindzorg
- Familienet, €99/mo per location, 1000+ orgs [V] — https://www.familienet.nl/
